ArticleJournal of immunology (Baltimore, Md. : 1950)2025
WDFY1-expressing follicular dendritic cells play a critical role in lupus development in cGVHD mouse model.
Article in Journal of immunology (Baltimore, Md. : 1950), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Follicular dendritic cells (FDCs) retain Ag-containing immune complexes (ICs), facilitate the selection of high-affinity antibodies, and protect B cells in germinal centers (GCs) from apoptosis. In systemic lupus erythematosus patients, apoptotic debris is found on the surface of FDCs. However, the mechanisms by which FDCs engage the protected autoreactive B cells remain unclear. WD repeat and FYVE domain-containing protein 1 (WDFY1) is an adaptor protein involved in endocytic/vacuolar membrane trafficking. We found that FDCs express a high level of WDFY1, which is required for their IC presentation. C57BL/6 mice deficient in WDFY1 generated significantly lesser titers of anti-dsDNA and anti-chromatin autoantibodies (autoAbs) than WDFY1-sufficient mice receiving an equal amount of CD4+ T cells from bm12 mice in the mouse model of inducible lupus. Decreased autoAb production in WDFY1-deficient mice correlates with less GC formation and fewer T and GC B cells in the follicle. Interestingly, T cells from WDFY1-KO mice remain capable of inducing comparable chronic graft-versus-host disease (cGVHD) in host bm12 mice as the T cells from WT mice. B cells from WDFY1-KO mice also remain capable of being fully activated and differentiated in response to independent Ag challenges. Immunofluorescence staining reveals reduced binding of ICs with FDCs in WDFY1-KO mice compared to WT control mice. Mixed leukocyte reaction results show no intrinsic defect in B cells. B-cell reconstitution in Rag1-KO mice also revealed that WDFY1 is critical for FDCs. Collectively, our studies indicate that WDFY1 knockout impairs the normal functioning of FDCs, resulting in reduced autoAb response to cGVHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.